AAA
KRRO icon

Affinity Asset Advisors’s Korro Bio KRRO Stock Holding History

Affinity Asset Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.32M Hold
706,904
– – 0.42% 62
2026
Q1 		$8M Buy
+706,904
New +$7.78M 0.41% 58

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Affinity Asset Advisors's KRRO Position: Q2 2026 in Review

Affinity Asset Advisors held its Korro Bio (KRRO) position steady in Q2 2026 at 706,904 shares worth $9.32M. The position accounts for 0.42% of the portfolio, ranked #62.

Affinity Asset Advisors first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Affinity Asset Advisors held 706,904 shares of Korro Bio worth $9.32M as of Q2 2026.
  • Affinity Asset Advisors left its Korro Bio share count unchanged in Q2 2026.
  • Korro Bio made up 0.42% of Affinity Asset Advisors's portfolio in Q2 2026, its #62 holding.
  • Affinity Asset Advisors first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.